Current Report Filing (8-k)
May 22 2020 - 6:07AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
May 18, 2020
SG BLOCKS, INC.
(Exact Name of Registrant as Specified in its
Charter)
Delaware
|
|
001-38037
|
|
95-4463937
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification Number)
|
195 Montague Street, 14th Floor
Brooklyn, NY 11201
(Address of Principal Executive Offices, Zip
Code)
Registrant’s telephone number, including
area code: 646-240-4235
Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class
|
|
Trading Symbol(s)
|
|
Name of Each Exchange on Which Registered
|
Common Stock, par value $0.01
|
|
SGBX
|
|
The Nasdaq Stock Market LLC
|
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by
check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
On May 18, 2020, SG Blocks, Inc. (the
“Company”) completed its U.S. import registration for the import into the United States of the “GeneFinder®
COVID-19 Plus RealAmp Kit” produced by OSANG Healthcare Co., Ltd. (“OHC”), a South Korea based global manufacturer
and distributor of medical-grade diagnostic tests and equipment.
The “GeneFinder® COVID-19 Plus
RealAmp Kit” test is a polymerase chain reaction (PCR) SARS-CoV-2 test for COVID-19 available in the United States under
the FDA’s Emergency Use Authorization. On May 5, 2020, the Company announced the signing of a one-year, non-exclusive distributorship
agreement with OHC for its “GeneFinder® COVID-19 Plus RealAmp Kit” in the United States.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
SG Blocks, Inc.
|
|
|
|
Dated: May 22, 2020
|
By:
|
/s/ Paul Galvin
|
|
|
Paul Galvin
|
|
|
Chairman and CEO
|
Safe and Green (NASDAQ:SGBX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Safe and Green (NASDAQ:SGBX)
Historical Stock Chart
From Sep 2023 to Sep 2024